Accelerating
breakthroughs in
regenerative
medicine

About Starfish Innovations

Starfish Innovations is an investment fund and commercialization hub that seeks to accelerate breakthroughs in regenerative medicine. Founded in 2016 by the Leiden University Medical Centre (LUMC), we have been able to build a strong early-stage pipeline of regenerative medicine technologies through our direct access to the promising science at LUMC as well as our global network of academic institutions and industry alike.

More About Us

Starfish are famous for their ability to regenerate their limbs. In fact,
a few species can
regenerate a whole new 
body from just a single arm.

Latest Investments

More

Latest press release

NTrans Technologies closes Series A investment to accelerate development of gene editing therapy

| starfish |

May 27, 2021

Utrecht, The Netherlands – NTrans Technologies (NTrans), a leader in gene editing technologies, today announced a Series A investment of 2 million Euros, led by Essential Investments, together with BOP Capital, Utrecht Health Seed Fund, and Starfish Innovations. Through this investment, NTrans aims to advance the development of its gene editing-based therapy for Duchenne Muscular Dystrophy (DMD). The funds will be used to demonstrate preclinical efficacy and safety of the therapy in DMD disease models, in preparation for its progression to the clinic.

Read more

Stay up to date with news, inspirations and events.

© Starfish Innovations. All rights reserved.